Silence Therapeutics Plc. (SLN) NASDAQ

$20.67 (1.50) (-6.77%)

Market Cap: $663.51M

As of 04/15/24 03:59 PM EDT. Market closed.

(SLN)

Silence Therapeutics Plc. (SLN)
NASDAQ

$20.67
(1.50) (-6.77%)

Market Cap: $663.51M

As of 04/15/24 03:59 PM EDT. Market closed.

Add to Portfolio

silence therapeutics develops a new generation of medicines by harnessing the body’s natural mechanism of rna interference, or rnai, within its cells. our proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. using our enabling delivery systems, we have achieved an additional level of specificity by delivering ... read more

silence therapeutics develops a new generation of medicines by harnessing the body’s natural mechanism of rna interference, or rnai, within its cells. our proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. using our enabling delivery systems, we have achieved an additional level of specificity by delivering our therapeutic rna molecules exclusively to target cells. silence’s proprietary rna chemistries and delivery systems are designed to improve the stability of our molecules and enhance effective delivery to target cells, providing a powerful modular technology well suited to tackle life-threatening diseases. for more information, visit us at www.silence-therapeutics.com read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Craig A. Tooman
Full Time Employees
111
URL
Address
72 Hammersmith Road, UK, London, W14 8th.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Craig A. Tooman
Full Time Employees
111
Address
72 Hammersmith Road, UK, London, W14 8th.
PRICE CHART FOR SILENCE THERAPEUTICS PLC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$22.63
Previous Close
$22.17
Days Range
$21.97 - $22.80
52 week range
$4.55 - $27.72
Volume
77,611
Avg. Volume (30 days)
159,420
Market Cap
$663.51M
Dividend Yield
-
P/E
-
Shares Outstanding
29,928,240
Open
$22.63
Previous Close
$22.17
Days Range
$21.97 - $22.80
52 week range
$4.55 - $27.72
Volume
77,611
Avg. Volume (30 days)
159,420
Market Cap
$663.51M
Dividend Yield
-
P/E
-
Shares Outstanding
29,928,240
FINANCIAL STATEMENTS FOR SILENCE THERAPEUTICS PLC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

FUNDS WITH A POSITION IN SILENCE THERAPEUTICS PLC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
VIVO CAPITAL, LLC510,2040.73%NewOther
UBS OCONNOR LLC93,1980.12%-5.22%Value
RENAISSANCE TECHNOLOGIES LLC27,1020.00073%NewOther
GEODE CAPITAL MANAGEMENT, LLC22,4270.00004%5.17%Other
CHANGE IN SHARES OUTSTANDING FOR SILENCE THERAPEUTICS PLC
STOCK BUYBACKS FOR SILENCE THERAPEUTICS PLC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
6.93%
1Q
12/31/2023
06/30/2023
7.36%
2Q
12/31/2023
03/31/2023
7.61%
3Q
12/31/2023
12/31/2022
7.74%
4Q
12/31/2023
09/30/2022
29.16%
5Q
12/31/2023
06/30/2022
29.20%
6Q
12/31/2023
03/31/2022
29.21%
7Q
12/31/2023
12/31/2021
29.22%
8Q
12/31/2023
09/30/2021
29.28%
9Q
12/31/2023
06/30/2021
39.26%
10Q
12/31/2023
03/31/2021
39.26%
11Q
12/31/2023
12/31/2020
48.03%
12Q
12/31/2023
09/30/2020
48.03%
13Q
12/31/2023
06/30/2020
48.03%
14Q
12/31/2023
12/31/2019
48.03%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
6.93%
1Q
06/30/2023
7.36%
2Q
03/31/2023
7.61%
3Q
12/31/2022
7.74%
4Q
09/30/2022
29.16%
5Q
06/30/2022
29.20%
6Q
03/31/2022
29.21%
7Q
12/31/2021
29.22%
8Q
09/30/2021
29.28%
9Q
06/30/2021
39.26%
10Q
03/31/2021
39.26%
11Q
12/31/2020
48.03%
12Q
09/30/2020
48.03%
13Q
06/30/2020
48.03%
14Q
12/31/2019
48.03%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR SILENCE THERAPEUTICS PLC
LOADING...